HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.

Abstract
Emblica officinalis (EO) has antioxidant properties that could improve redox-sensitive vascular, cardiac and renal changes associated with deoxycorticosterone acetate/1% NaCl high salt (DOCA/HS)-induced hypertension. We determined whether hydroalcoholic lyophilized extract of EO may influence DOCA/HS-induced hypertension by modulating activity of (p) eNOS and endogenous antioxidants. Hypertension was induced in rats by DOCA-salt (20 mg/kg, s.c.) twice weekly for 5 weeks and replacing drinking water with 1% NaCl solution. These rats received cotreatment of different doses of EO (75, 150 and 300 mg/kg/day) for 5 weeks. EO significantly decreased arterial blood pressure and heart rate along with cardiac and renal hypertrophy in a dose-dependent fashion as compared to DOCA control rats. Increased TBARS and decreased endogenous antioxidants including GSH, SOD and GSHPx activity in serum, heart and kidney tissues of hypertensive rats were also normalized. Furthermore, this antihypertensive activity of EO was also linked with increased serum NO, K(+) levels and decreased Na(+) levels. Moreover, EO robustly increased activated eNOS expression in heart. Our results demonstrate that EO reduces oxidative stress, prevents development and progression of hypertension as well as cardiac and renal hypertrophy in DOCA/HS-induced hypertension via modulation of activated eNOS, endogenous antioxidants, serum NO and electrolyte levels.
AuthorsJagriti Bhatia, Fauzia Tabassum, Ashok Kumar Sharma, Saurabh Bharti, Mahaveer Golechha, Sujata Joshi, Md Sayeed Akhatar, Abhay Krishna Srivastava, Dharamvir Singh Arya
JournalCardiovascular toxicology (Cardiovasc Toxicol) Vol. 11 Issue 3 Pg. 272-9 (Sep 2011) ISSN: 1559-0259 [Electronic] United States
PMID21748534 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Plant Extracts
  • Sodium Chloride, Dietary
  • Thiobarbituric Acid Reactive Substances
  • Nitric Oxide
  • Desoxycorticosterone
  • Glutathione Peroxidase
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Superoxide Dismutase
  • Glutathione
  • Potassium
Topics
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Blood Pressure (drug effects)
  • Cardiomegaly (enzymology, prevention & control)
  • Desoxycorticosterone
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Glutathione (metabolism)
  • Glutathione Peroxidase (metabolism)
  • Hypertension (chemically induced, drug therapy, enzymology, physiopathology)
  • Kidney Diseases (enzymology, prevention & control)
  • Male
  • Nitric Oxide (blood)
  • Nitric Oxide Synthase Type III (metabolism)
  • Oxidative Stress (drug effects)
  • Phosphorylation
  • Phyllanthus emblica
  • Plant Extracts (pharmacology)
  • Potassium (blood)
  • Rats
  • Sodium Chloride, Dietary (blood)
  • Superoxide Dismutase (metabolism)
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: